CNS Pharmaceuticals Inc (CNSP)
0.111
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
0.1124
0.00 (0.00%)
After-Hours: 20:00
CNS Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ligand Pharmaceuticals Inc | 0.00 |
| Cellectar Biosciences Inc | -- |
| Revance Therapeutics Inc | -2.645 |
| Zymeworks Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.409M |
| Total Liabilities (Quarterly) | 4.057M |
| Shareholders Equity (Quarterly) | 3.352M |